Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week

European Journal of Pharmacology

Volumn 765, Issue , 2015, Pages 249-257

  Shao, Yuan ^a   Peng, Hui ^b   Huang, Qingjun ^a   Kong, Jiming ^c   Xu, Haiyun ^a,b  

^a SHANDONG MENTAL HEALTH CENTER   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antipsychotic; Cuprizone; Mice; Neuroinflammation; Oligodendrocytes; Schizophrenia

Indexed keywords

CUPRIZONE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; PROSTAGLANDIN E2; QUETIAPINE; TUMOR NECROSIS FACTOR ALPHA; NEUROLEPTIC AGENT;

ADULT; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BEHAVIOR CHANGE; BRAIN CORTEX; BRAIN REGION; CELL ACTIVATION; CONTROLLED STUDY; CORPUS CALLOSUM; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LOCOMOTION; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OLIGODENDROGLIA; OPEN FIELD BEHAVIOR; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PUTAMEN; Y-MAZE TEST; YOUNG ADULT; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ENCEPHALITIS; IMMUNOLOGY; MAZE TEST; MOTOR ACTIVITY; PATHOLOGY; PSYCHOLOGY;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CUPRIZONE; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MAZE LEARNING; MICE, INBRED C57BL; MOTOR ACTIVITY; OLIGODENDROGLIA; QUETIAPINE FUMARATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940730062     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.08.046     Document Type: Article

References (53)

1. N.C. Andreasen The evolving concept of schizophrenia: from Kraepelin to the present and future Schizophr. Res. 28 1997 105 109
2. V. Babulas, P. Factor-Litvak, R. Goetz, C.A. Schaefer, and A.S. Brown Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia Am. J. Psychiatry 163 2006 927 929
3. A. Basta-Kaim, E. Szczesny, M. Leskiewicz, K. Glombik, J. Slusarczyk, B. Budziszewska, M. Regulska, M. Kubera, W. Nowak, K. Wędzony, and W. Lasoń, Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring-the effect of antipsychotic drugs Pharmacol. Rep. 64 2012 1400 1410
4. T.A. Bayer, R. Buslei, L. Havas, and P. Falkai Evidence for activation of microglia in patients with psychiatric illnesses Neurosci. Lett. 271 1999 126 128
5. Q. Bian, T. Kato, A. Monji, S. Hashioka, Y. Mizoguchi, H. Horikawa, and S. Kanba The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 42 48
6. B.K. Bitanihirwe, D. Peleg-Raibstein, F. Mouttet, J. Feldon, and U. Meyer Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia Neuropsychopharmacology 35 2010 2462 2478
7. A.S. Brown, P. Cohen, J. Harkavy-Friedman, V. Babulas, D. Malaspina, J.M. Gorman, and E.S. Susser A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia Biol. Psychiatry 49 2001 473 486
8. A.S. Brown, J. Hooton, C.A. Schaefer, H. Zhang, E. Petkova, V. Babulas, M. Perrin, J.M. Gorman, and E.S. Susser Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring Am. J. Psychiatry 161 2004 889 895
9. A.S. Brown, C.A. Schaefer, C.P. Quesenberry Jr., L. Liu, V.P. Babulas, and E.S. Susser Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring Am. J. Psychiatry 162 2005 767 773
10. S.L. Buka, M.T. Tsuang, E.F. Torrey, M.A. Klebanoff, D. Bernstein, and R.H. Yolken Maternal infections and subsequent psychosis among offspring Arch. Gen. Psychiatry 58 2001 1032 1037
11. W. Cammer, and H. Zhang Maturation of oligodendrocytes is more sensitive to TNF alpha than is survival of precursors and immature oligodendrocytes J. Neuroimmunol. 97 1999 37 42
12. V.S. Catts, J. Wong, S.G. Fillman, S.J. Fung, and C.S. Weickert Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation Aust. N. Z. J. Psychiatry 48 2014 722 734
13. C. Chaves, C.R. Marque, J.P. Maia-de-Oliveira, L. Wichert-Ana, T.B. Ferrari, A.C. Santos, D. Araújo, J.P. Machado-de-Sousa, R.A. Bressan, H. Elkis, J.A. Crippa, F.S. Guimarães, A.W. Zuardi, G.B. Baker, S.M. Dursun, and J.E. Hallak Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia Schizophr. Res. 161 2015 439 445
14. H.W. Dong Allen Reference Atlas: A Digital Color Brain Atlas of the C57BL/6j Male Mouse 2007 Wiley Sesttle
15. B. Feldhaus, I.D. Dietzel, R. Heumann, and R. Berger Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors J. Soc. Gynecol. Investig. 11 2004 89 96
16. A. Ghanizadeh, S. Dehbozorgi, M. OmraniSigaroodi, and Z. Rezaei Minocycline as add-on treatment decreases the negative symptoms of schizophrenia; a randomized placebo-controlled clinical trial Recent Pat. Inflamm. Allergy Drug Discov. 8 2014 211 215
17. J. Goldberg, M. Daniel, Y. van Heuvel, M. Victor, C. Beyer, T. Clarner, and M. Kipp Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes Cell. Mol. Neurobiol. 33 2013 1087 1098
18. H. Kim, J. Bang, H.W. Chang, J.Y. Kim, K.U. Park, S.H. Kim, K.J. Lee, C.H. Cho, I. Hwang, S.D. Park, E. Ha, and S.W. Jung Anti-inflammatory effect of quetiapine on collagen-induced arthritis of mouse Eur. J. Pharmacol. 678 2012 55 60
19. A.A. Mathe, G. Sedvall, F.A. Wiesel, and H. Nyback Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia Lancet 1 1980 16 18
20. S.A. Mednick, R.A. Machon, M.O. Huttunen, and D. Bonett Adult schizophrenia following prenatal exposure to an influenza epidemic Arch. Gen. Psychiatry 45 1988 189 192
21. F. Mei, S. Guo, Y. He, L. Wang, H. Wang, J. Niu, J. Kong, X. Li, Y. Wu, and L. Xiao Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation PLoS One 7 2012 e42746
22. U. Meyer, M. Nyffeler, B.K. Yee, I. Knuesel, and J. Feldon Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice Brain Behav. Immun. 22 2008 469 486
23. B.J. Miller, P. Buckley, W. Seabolt, A. Mellor, and B. Kirkpatrick Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects Biol. Psychiatry 70 2011 663 671
24. P.B. Mortensen, B. Norgaard-Pedersen, B.L. Waltoft, T.L. Sorensen, D. Hougaard, and R.H. Yolken Early infections of Toxoplasma gondii and the later development of schizophrenia Schizophr. Bull. 33 2007 741 744
25. N. Muller, and M.J. Schwarz Immune system and schizophrenia Curr. Immunol. Rev. 6 2010 213 220
26. S. Najjar, D.M. Pearlman, K. Alper, A. Najjar, and O. Devinsky Neuroinflammation and psychiatric illness J. Neuroinflamm. 10 2013 43 10.1186/1742-2094-10-43
27. H. Nakanishi, and Z. Wu Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging Behav. Brain Res. 201 2009 1 7
28. K. Oya, T. Kishi, and N. Iwata Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials Hum. Psychopharmacol. 29 2014 483 491
29. S. Potvin, E. Stip, A.A. Sepehry, A. Gendron, R. Bah, and E. Kouassi. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review Biol. Psychiatry 63 2008 801 808
30. K. Radewicz, L.J. Garey, S.M. Gentleman, and R. Reynolds Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics J. Neuropathol. Exp. Neurol. 59 2000 137 150
31. G. Ramesh, S. Benge, B. Pahar, and M.T. Philipp A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi J. Neuroinflamm. 9 2012 72 10.1186/1742-2094-9-72
32. R.M. Ransohoff, and A.E. Cardona The myeloid cells of the central nervous system parenchyma Nature 468 2010 253 262
33. R.M. Ransohoff, and V.H. Perry Microglial physiology: unique stimuli, specialized responses Annu. Rev. Immunol. 27 2009 119 145
34. W. Sano, T. Nakamura, K. Yoshiuchi, T. Kitajima, A. Tsuchiya, Y. Esaki, Y. Yamamoto, and N. Iwata Enhanced persistency of resting and active periods of locomotor activity in schizophrenia PLoS One 7 2012 e43539
35. P. Seth, and N. Koul Astrocyte, the star avatar: redefined J. Biosci. 33 2008 405 421
36. I.E. Sommer, L. de Witte, M. Begemann, and R.S. Kahn Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis J. Clin. Psychiatry 73 2012 414 419
37. H.J. Sorensen, E.L. Mortensen, J.M. Reinisch, and S.A. Mednick Association between prenatal exposure to bacterial infection and risk of schizophrenia Schizophr. Bull. 35 2009 631 637
38. J. Steiner, C. Mawrin, A. Ziegeler, H. Bielau, O. Ullrich, H.G. Bernstein, and B. Bogerts Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization Acta Neuropathol. 112 2006 305 316
39. H. Sugino, T. Futamura, Y. Mitsumoto, K. Maeda, and Y. Marunaka Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 303 307
40. J. Suvisaari, J. Haukka, A. Tanskanen, T. Hovi, and J. Lonnqvist Association between prenatal exposure to poliovirus infection and adult schizophrenia Am. J. Psychiatry 156 1999 1100 1102
41. T. Tezuka, M. Tamura, M.A. Kondo, M. Sakaue, K. Okada, K. Takemoto, A. Fukunari, K. Miwa, H. Ohzeki, S. Kano, H. Yasumatsu, A. Sawa, and Y. Kajii Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis Neurobiol. Dis. 59 2013 63 68
42. E.F. Torrey, R. Rawlings, and I.N. Waldman Schizophrenic births and viral diseases in two states Schizophr. Res. 1 1988 73 77
43. H. Wang, H. Xu, L.E. Dyck, and X.M. Li Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis J. Neurosci. Res. 81 2005 572 580
44. L. Wischhof, E. Irrsack, C. Osorio, and M. Koch Prenatal LPS-exposure - a neuro- developmental rat model of schizophrenia - differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspring Prog. Neuropsychopharmacol. Biol. Psychiatry 57 2015 17 30
45. L. Xiao, H. Xu, Y. Zhang, Z. Wei, J. He, W. Jiang, X. Li, L.E. Dyck, R.M. Devon, Y. Deng, and X.M. Li Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes Mol. Psychiatry 13 2008 697 708
46. H. Xu, H. Wang, L. Zhuang, B. Yan, Y. Yu, Z. Wei, Y. Zhang, L.E. Dyck, S.J. Richardson, J. He, X. Li, J. Kong, and X.M. Li Demonstration of an anti-oxidative stress mechanism of quetiapine: implications for the treatment of Alzheimer's disease FEBS J. 275 2008 3718 3728
47. H. Xu, H.J. Yang, and X.M. Li Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone Eur. Arch. Psychiatry Clin. Neurosci. 264 2014 121 129
48. H. Xu, H.J. Yang, Y. Zhang, R. Clough, R. Browning, and X.M. Li Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone Behav. Neurosci. 123 2009 418 429
49. Y. Xuan, G. Yan, H. Peng, R. Wu, and H. Xu Concurrent changes in (1)H MRS metabolites and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to cuprizone: possible implications for schizophrenia Neurochem. Int. 69 2014 20 27
50. H.J. Yang, H. Wang, Y. Zhang, L. Xiao, R.W. Clough, R. Browning, X.M. Li, and H. Xu Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia Brain Res. 1270 2009 121 130
51. H. Zhang, Y. Zhang, H. Xu, L. Wang, J. Zhao, J. Wang, Z. Zhang, Q. Tan, J. Kong, Q. Huang, and X.M. Li Locomotor activity and anxiety status, but not spatial working memory, are affected in mice after brief exposure to cuprizone Neurosci. Bull. 29 2013 633 641
52. Y. Zhang, H. Xu, W. Jiang, L. Xiao, B. Yan, J. He, Y. Wang, X. Bi, X. Li, J. Kong, and X.M. Li Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse Schizophr. Res. 106 2008 182 191
53. F. Zhu, Y. Zheng, Y.Q. Ding, Y. Liu, X. Zhang, R. Wu, X. Guo, and J. Zhao Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats PLoS One 9 2014 e93966